UCLH-6630 - LECANEMAB HOMECARE SERVICE
The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to pr...
Buyer
UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST
Value
£816,000
Published
5 Mar 2025
Closes
26 Mar 2025
Procurement details
Source
Contracts Finder
Region
Camden and City of London
Procurement method
Open
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
85149000
Pharmacy services
Lots
Lot default UCLH-6630 - LECANEMAB HOMECARE SERVICE
£816,000
The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The servic...
Delivery: England · United Kingdom, England, United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
5 Mar 2025
Opportunity notice on Contracts Finder
Tender notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.